Cargando…
Pseudomyogenic hemangioendothelioma of bone with rare WWTR1‐FOSB fusion gene: Case report and literature review
Pseudomyogenic hemangioendothelioma rarely arises in bone. WWTR1‐FOSB fusion gene is rarely reported in PMHE of bone. Currently, fusion genes can be used as diagnostic markers in PMHE; however, their prognostic and therapeutic significance is unclear.
Autores principales: | Murshed, Khaled A., Torres‐Mora, Jorge, ElSayed, Ahmed Mounir, Ammar, Adham, Al‐Bozom, Issam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981765/ https://www.ncbi.nlm.nih.gov/pubmed/33768875 http://dx.doi.org/10.1002/ccr3.3808 |
Ejemplares similares
-
Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics
por: Sugita, Shintaro, et al.
Publicado: (2016) -
Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma
por: Zhu, Guo, et al.
Publicado: (2018) -
Clinicopathological study of pseudomyogenic hemangioendothelioma
por: Yang, Ningning, et al.
Publicado: (2023) -
Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma
por: Joseph, Jason, et al.
Publicado: (2015) -
A Case of Pseudomyogenic Hemangioendothelioma of the Lower Extremity
por: Choi, Myoung Eun, et al.
Publicado: (2020)